Follow
Timon Vandamme
Timon Vandamme
Consultant digestive and (neuro)endocrine oncology fellow, University Hospital Antwerp
Verified email at uantwerp.be - Homepage
Title
Cited by
Cited by
Year
Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1
T Vandamme, M Peeters, F Dogan, P Pauwels, E Van Assche, M Beyens, ...
Journal of molecular endocrinology.-Bristol 54 (2), 137-147, 2015
792015
Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors
T Vandamme, M Beyens, KO de Beeck, F Dogan, PM van Koetsveld, ...
British journal of cancer 114 (6), 650-658, 2016
662016
Serum neuron-specific enolase level is an independent predictor of overall survival in patients with gastroenteropancreatic neuroendocrine tumors
RCS van Adrichem, K Kamp, T Vandamme, M Peeters, RA Feelders, ...
Annals of Oncology 27 (4), 746-747, 2016
362016
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment
M Peeters, L Verbruggen, L Teuwen, G Vanhoutte, SV Kerckhove, ...
ESMO open 6 (5), 100274, 2021
232021
Cancer-associated fibroblasts as a common orchestrator of therapy resistance in lung and pancreatic cancer
A Domen, D Quatannens, S Zanivan, C Deben, J Van Audenaerde, ...
Cancers 13 (5), 987, 2021
222021
Cell-free DNA from metastatic pancreatic neuroendocrine tumor patients contains tumor-specific mutations and copy number variations
G Boons, T Vandamme, M Peeters, M Beyens, A Driessen, K Janssens, ...
Frontiers in oncology, 467, 2018
222018
Resistance to targeted treatment of gastroenteropancreatic neuroendocrine tumors
M Beyens, T Vandamme, M Peeters, G Van Camp, KO de Beeck
Endocrine-related cancer 26 (3), R109-R130, 2019
202019
Hotspot DAXX, PTCH2 and CYFIP2 mutations in pancreatic neuroendocrine neoplasms
T Vandamme, M Beyens, G Boons, A Schepers, K Kamp, K Biermann, ...
Endocrine-related cancer 26 (1), 1-12, 2019
152019
Next generation exome sequencing of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1 reveals different lineages
T Vandamme, M Beyens, M Peeters, G Van Camp, KO de Beeck
Cancer genetics 208 (10), 523, 2015
142015
Clinical applications of (epi) genetics in gastroenteropancreatic neuroendocrine neoplasms: moving towards liquid biopsies
G Boons, T Vandamme, M Peeters, G Van Camp, K Op de Beeck
Reviews in Endocrine and Metabolic Disorders 20 (3), 333-351, 2019
112019
PDX1 DNA Methylation Distinguishes Two Subtypes of Pancreatic Neuroendocrine Neoplasms with a Different Prognosis
G Boons, T Vandamme, J Ibrahim, G Roeyen, A Driessen, D Peeters, ...
Cancers 12 (6), 1461, 2020
92020
Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer
Y Debie, T Vandamme, ME Goossens, PA van Dam, M Peeters
European Journal of Cancer 163, 177, 2022
62022
Hormone and receptor candidates for target and biotherapy of neuroendocrine tumors
LJ Hofland, T Vandamme, M Albertelli, D Ferone
Neuroendocrine Tumors: A Multidisciplinary Approach 44, 216-238, 2015
52015
Hyperammonemic encephalopathy in diffuse liver metastasis: is this the end stage?
T Vandamme, J Kunnen, M Simoens
Gastroenterology 143 (1), e9-e10, 2012
52012
Should Anti-EGFR Agents Be Used in Right-Sided RAS Wild-type Advanced Colorectal Cancer?
L Triest, C Debeuckelaere, T Vandamme, B Van Den Heuvel, ...
Current Colorectal Cancer Reports 15 (4), 130-134, 2019
32019
Longitudinal Copy-Number Alteration Analysis in Plasma Cell-Free DNA of Neuroendocrine Neoplasms is a Novel Specific Biomarker for Diagnosis, Prognosis, and Follow-up
G Boons, T Vandamme, L MariŽn, W Lybaert, G Roeyen, T Rondou, ...
Clinical Cancer Research 28 (2), 338-349, 2022
22022
Reduced humoral immune response after BNT162B2 COVID-19 MRNA vaccination in cancer patients under anti-neoplastic treatment
M Peeters, L Verbruggen, L Teuwen, G Vanhoutte, SV Kerckhove, ...
ESMO Open, 2021
22021
Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer
Y Debie, T Vandamme, ME Goossens, PA van Dam, M Peeters
European Journal of Cancer 163, 177-179, 2022
12022
Gastric MALT-Lymphoma: more than Helicobacter Pylori
G Van de Vyver, T Vandamme, PH Steger, D Staessen
Acta gastro-enterologica Belgica 84 (4), 2021
12021
Gastrointestinal: refractory dyspepsia due to primary gastric amyloidosis: sometimes you have to dig deeper
E Van Mieghem, T Vandamme, F Deman, T Eyckmans, D Staessen
Journal of Gastroenterology and Hepatology 36 (5), 1149-1149, 2021
12021
The system can't perform the operation now. Try again later.
Articles 1–20